|
|
|
Day One – November 13
|
8:00am |
Registration
|
|
9:00am |
Day One: Nanopharmaceuticals
Introduction and Opening Remarks: Professor K.K. Jain, CEO, Jain Pharmabiotech
|
|
9:05am |
Keynote Address – Rational Design of Anti-Biobarrier Nanotechnology
Mauro Ferrari, Professor, University of Texas Health Center,
M.D. Anderson Cancer Center,
Rice University
|
|
9:50am |
Coffee & networking in exhibit hall
|
|
10:35am |
Drug Discovery
Session Chair - Professor K.K. Jain, CEO, Jain Pharmabiotech
|
|
10:40am |
Preclinical Testing of Engineered Nanomaterials Designed for Biomedical Applications
Parag Aggarwal, Post-Doctoral Fellow, NCI Frederick - Nanotechnology Characterization Lab
|
|
11:10am |
Engineering of Novel ZnO Nanomaterial Platforms for Enhanced Biomedical Detection
Jong-in Hahm, Assistant Professor, Pennsylvania State University
|
|
11:40am |
Drug Delivery
Session Chair - Mark Milton, VP Non Clinical Development, Tempo Pharmaceuticals
|
|
11:45am |
Nanoparticle Albumin Bound (nab) Technology: Targeting Tumors through the endothelial gp60 receptor and SPARC
Neil Desai, Vice President – R&D, Abraxis Bioscience
Abraxane (nab-paclitaxel) is the first FDA-approved nanotechnology-based chemotherapeutic showing significant clinical benefit versus Taxol and Taxotere in breast cancer. The talk discusses mechanisms of targeting and transport for nab-platform and its utility as a broad platform for targeted chemotherapy.
|
|
12:15pm |
Lunch and poster viewing
|
|
1:45pm |
Small Interfering RNA Delivery and Gene Silencing Using Polymeric Nanoparticles
Ken Howard, iNano
|
|
2:15pm |
Porosity Effect on Phenytoin Release from Titania Nanoreservoirs to the Temporal Lobe of Epileptic Rats
Richard Gonzalez, Professor, Tulane University
Nanomedicine drug therapy represents an important means to treat a variety of neurological disorders like epilepsy. Using a nanoreservoir with valproic acid occluded and implanting it in the temporal lobe is possible to control the epileptic crisis for one year.
|
|
2:45pm |
Coffee & networking in exhibit hall |
|
3:30pm |
Temporal Targeting of Tumor Cells and Neovasculature with a NanoCell
Mark Milton, VP Non Clinical Development, Tempo Pharmaceuticals
|
|
4:00pm |
Lateral Flow Device for the Detection of Cerebrospinal Fluid Leaks
Srinivas Pentyala, Director of Translational Research and Associate Professor, Stonybrook Medical Center
Monoclonal and polyclonal antibodies were conjugated to latex nanobeads and validated in a lateral flow device for rapid bed side detection of Cerebrospinal fluid leaks. |
|
4:30pm |
Drinks Reception Compliments of metanomics Health |
|
|
|
Day Two – November 14
|
|
Day Two: Clinical Applications of Nanobiotechnology
|
| 9:00am |
Nanomedicine
Session Chair - Professor K. K. Jain, CEO, Jain Pharmabiotech
|
| 9:05am |
Keynote Address – Advances in Nanomedicine
K.K. Jain, CEO, Jain Pharmabiotech
|
| 9:50am |
Coffee & networking in exhibit hall
|
| 10:35am |
Thiolato-Gold-Nanocrystals-on-Gold CYP3A4 Nanobiosensor Platform for Protease Inhibitor Anti-HIV Drugs
Emmanuel Iwuoha, Professor, University of the Western Cape
Novel nanobiosensors for antiretroviral drugs of the protease inhibitor types are presented. The sensor platforms were developed with self assembled mercaptoproionate- or L-lysine-modified gold-nanocrystals-on-gold (GNG) or polyaniline nanotubes-on-gold (PNG) onto which cytochrome P450-3A4 (CYP3A4) were electrophoretically incorporated.
|
| 11:05am |
Ethical and Social Considerations of Nanomedicine
Jan Jaeger, Assistant Professor, University of Pennsylvania
|
| 11:35am |
Influence of Nano Aligned Titanium Patterns on Osteoblast Adhesion
Sabrina Puckett, Graduate Student, Brown University
This study indicates that nanopatterned titanium surfaces better promote the formation of anisotropic bone by increasing the adhesion of osteoblast cells when compared to nonaligned nano surfaces.
|
| 12:05pm |
Lunch & poster viewing
|
|
1:35pm |
Diagnostics
Session Chair - Warren Chan, Assistant Professor, University of Toronto
|
|
1:40pm |
Quantum Dots for in vitro Diagnostics
Warren Chan, Assistant Professor, University of Toronto
|
|
2:10pm |
Novel DNA-Mounted Fluorescence Bio-Assay Systems for Molecular Diagnostics
Elena Bichenkova, Lecturer, University of Manchester
The presentations outlines novel approaches for in situ detection of nucleic acids as a basis for development of new technology platforms for genomic and post-genomic molecular diagnostics.
|
|
2:40pm |
Nanotechnology and Nanomedicine at the Crossroads
Igor Linkov, Managing Scientist, Intertox
|
|
3:10pm |
Coffee & Close of Conference |
|